In the present study, we evaluated plasma levels of the prototypical acute phase protein CRP, Interleukin-1 receptor antagonist (IL-1Ra) which is synthesized and released by activated monocyte-macrophages at sites of tissue damageyinflammation and Interleukin-2 soluble receptor (sIL-2R), a specific marker of T-lymphocyte activation, in patients with mild ischaemic LVD.

Plasma concentrations of interleukin-2 soluble receptor in mild ischaemic left ventricular dysfunction.

FIOTTI, NICOLA;GIANSANTE, CARLO;GUARNIERI, GIANFRANCO;DOBRINA, ALDO
2003-01-01

Abstract

In the present study, we evaluated plasma levels of the prototypical acute phase protein CRP, Interleukin-1 receptor antagonist (IL-1Ra) which is synthesized and released by activated monocyte-macrophages at sites of tissue damageyinflammation and Interleukin-2 soluble receptor (sIL-2R), a specific marker of T-lymphocyte activation, in patients with mild ischaemic LVD.
File in questo prodotto:
File Dimensione Formato  
03 plasma.pdf

Accesso chiuso

Tipologia: Documento in Versione Editoriale
Licenza: Digital Rights Management non definito
Dimensione 198.41 kB
Formato Adobe PDF
198.41 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11368/1709059
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 9
  • ???jsp.display-item.citation.isi??? 9
social impact